GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kangji Medical Holdings Ltd (HKSE:09997) » Definitions » 3-Year FCF Growth Rate

Kangji Medical Holdings (HKSE:09997) 3-Year FCF Growth Rate : 7.30% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Kangji Medical Holdings 3-Year FCF Growth Rate?

Kangji Medical Holdings's Free Cash Flow per Share for the six months ended in Dec. 2023 was HK$0.18.

During the past 12 months, Kangji Medical Holdings's average Free Cash Flow per Share Growth Rate was 63.50% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 7.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 6.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 7 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Kangji Medical Holdings was 32.70% per year. The lowest was -12.40% per year. And the median was 17.00% per year.


Competitive Comparison of Kangji Medical Holdings's 3-Year FCF Growth Rate

For the Medical Instruments & Supplies subindustry, Kangji Medical Holdings's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kangji Medical Holdings's 3-Year FCF Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kangji Medical Holdings's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Kangji Medical Holdings's 3-Year FCF Growth Rate falls into.



Kangji Medical Holdings 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Kangji Medical Holdings  (HKSE:09997) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Kangji Medical Holdings 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Kangji Medical Holdings's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Kangji Medical Holdings (HKSE:09997) Business Description

Traded in Other Exchanges
Address
No. 1668 Chunjiang East Road, Tonglu Economic Development Zone, Zhejiang Province, Hangzhou, CHN
Kangji Medical Holdings Ltd is engaged in the production and sales of minimally invasive surgical instruments and accessories. The company offers a product portfolio to provide physicians and hospitals with one-shop and tailored surgical solutions for four surgical specialties OBGYN, general surgery, urology, and thoracic surgery. It manufactures and sells both disposable and reusable products. Its product portfolio includes disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, and reusable trocar and forceps. It derives the majority of its revenue from Mainland China.
Executives
Butterfield Trust (asia) Limited 2301 Trustee
Fortune Spring Zm Aa Limited 2101 Beneficial owner
Yg Aa Limited 2201 Interest of corporation controlled by you
Bos Trustee Limited 2201 Interest of corporation controlled by you
Zhong Ming 2501 Other
Fortune Spring Yg B Limited 2101 Beneficial owner
Shentu Yinguang 2501 Other
Fortune Spring Zm B Limited 2101 Beneficial owner
Credit Suisse Trust Limited 2201 Interest of corporation controlled by you
Bonderman David 2201 Interest of corporation controlled by you
Coulter James George 2201 Interest of corporation controlled by you
Keyhole Holding Limited 2101 Beneficial owner
Tpg Asia Genpar Vii Advisors, Inc. 2201 Interest of corporation controlled by you
Tpg Asia Genpar Vii, L.p. 2201 Interest of corporation controlled by you
Tpg Group Holdings (sbs) Advisors, Inc. 2201 Interest of corporation controlled by you

Kangji Medical Holdings (HKSE:09997) Headlines

No Headlines